During the past decade, Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie" are "Metastatic Colorectal Cancer" (2 trials), "Breast Cancer" (1 trials), "Refractory Metastatic Colorectal Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie" in a lesser frequency.

Most popular intervention types in "Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Bevacizumab control" (1 trials), "Bevacizumab experimental" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".